The FDA warned clinicians the SARS-CoV-2 virus, which causes COVID-19, may be transmitted in fecal samples during fecal microbiota transplants.
What you should know:
1. Although transmission risk during FMT remains unknown, because of the possibility, the FDA has recommended additional safety precautions.
2. The FDA recommends clinicians or researchers use stool donated before Dec. 1, 2019, whenever possible.
3. If stool from before Dec. 1 is not available, clinicians or researchers should screen donors for COVID-19, test donors or the stool for COVID-19, and develop informed consent forms that warn of potential transmission.
Read the entire briefing here.